CRO Iconhas launched ICONIK Patient Safety, the latest service to leverage its ICONIK technology platform.

ICONIK Patient Safety offers a systematic way to monitor safety trends in accumulating data, spot potential safety issues and take appropriate corrective and preventative action while the study is ongoing. Data can be queried dynamically at any level of detail (single patient, single site, across an entire study or entire compound), helping sponsors make informed, data-driven decisions regarding patient treatment and safety, study direction and regulatory reporting. ICONIK Patient Safety eliminates the lengthy, manual review of individual patient files, allowing a faster and easier review of aggregated safety events across study populations.

Dr. Peter Schueler, senior vice president, medical and safety services, Icon Clinical Research, said, “Patient well-being is paramount in any clinical trial. ICONIK Patient Safety allows real-time review of integrated patient safety data, thereby improving our ability to identify and monitor unexpected adverse events. ICONIK Patient Safety helps study teams maintain a view of a drug’s evolving safety profile by accumulating safety data in real time and allowing for quick identification of emerging safety issues, affording greater protection of patients’ well-being.”